In this issue of Hematology/Oncology Clinics, guest editor Dr. Dario R. Roque brings his considerable expertise to the topic of Updates in Gynecologic Oncology. Top experts provide in-depth perspectives on key topics such as emerging therapeutic targets for platinum-resistant ovarian cancer; sexual health following diagnosis and treatment of gynecologic cancer; antibody–drug conjugates for the treatment of gynecologic cancer; surgery for recurrent ovarian cancer; and many more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer - p. 1057 9. Surgery for Recurrent Ovarian Cancer - p. 1077 10. Antibody–Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application - p. 1087 11. Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets - p. 1101 12. The Landscape of Personalized Medicine in Gynecologic Cancer - p. 1111 13. Advances in Cervical Cancer - p. 1121 14. Sentinel Lymph Node Sampling in Endometrial Cancers - p. 1139 15. Health Care Disparities in Gynecologic Oncology - p. 1157 16. Sexual Health Following Diagnosis and Treatment of Gynecologic Cancer - p. 1171
In this issue of Hematology/Oncology Clinics, guest editor Dr. Dario R. Roque brings his considerable expertise to the topic of Updates in Gynecologic Oncology. Top experts provide in-depth perspectives on key topics such as emerging therapeutic targets for platinum-resistant ovarian cancer; sexual health following diagnosis and treatment of gynecologic cancer; antibody–drug conjugates for the treatment of gynecologic cancer; surgery for recurrent ovarian cancer; and many more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Emerging Therapeutic Targets for Platinum-Resistant Ovarian Cancer - p. 1057 9. Surgery for Recurrent Ovarian Cancer - p. 1077 10. Antibody–Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application - p. 1087 11. Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets - p. 1101 12. The Landscape of Personalized Medicine in Gynecologic Cancer - p. 1111 13. Advances in Cervical Cancer - p. 1121 14. Sentinel Lymph Node Sampling in Endometrial Cancers - p. 1139 15. Health Care Disparities in Gynecologic Oncology - p. 1157 16. Sexual Health Following Diagnosis and Treatment of Gynecologic Cancer - p. 1171
